Effect of long-chain n-3 polyunsaturated fatty acid on inflammation mediators during osteoblastogenesis

Journal of Medicinal Food

Volumn 11, Issue 1, 2008, Pages 105-110

  Shen, Chwan Li ^a,c   Peterson, Jodie ^b   Tatum, Owatha L ^b   Dunn, Dale M ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Bone formation; Cyclooxygenase 2; Inducible nitric oxide synthase; Nitric oxide; Polyunsaturated fatty acid; Prostaglandin E2; Stromal cells

Indexed keywords

ALCOHOL; ARACHIDONIC ACID; AUTACOID; CYCLOOXYGENASE 2; CYTOKINE; ICOSAPENTAENOIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; LONG CHAIN FATTY ACID; MESSENGER RNA; NITRIC OXIDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN E2; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HYPOTHESIS; INFLAMMATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARACHIDONIC ACID; BONE MARROW CELLS; CELL LINE; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; DINOPROSTONE; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOBLASTS; RNA, MESSENGER; STROMAL CELLS;

EID: 41349087351     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.540     Document Type: Article

References (31)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 2001;285:785-795.
2. Mundy GR: Cytokine and growth factors in the regulation of bone remodeling. J Bone Miner Res 2003;8(Suppl 2):S505-S510.
3. Raisz LG: Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115:3318-3325.
4. Ralston SH, Ho L-P, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N: Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res 1995;10:1040-1049.
5. Cohen S: Role of RANK ligand in normal and pathologic bone remodeling and the therapeutic potential of novel inhibitory molecules in musculoskeletal diseases. Arthritis Rheum 2006;55:15-18.
6. Rauner M, Sipos W, Pietschmann P: Osteoimmunology. Int Arch Allergy Immunol 2006;143:31-48.
7. Li L, Pettit AR, Gregory LS, Forwood MR: Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name. Cytokine Growth Factor Rev 2006;17:203-216.
8. Okada Y, Pilbeam C, Raisz L, Tanaka Y: Role of cyclooxygenase-2 in bone resorption. J UOEH 2003;25:185-195.
9. Kobayashi Y, Take I, Yamashita T, Mizoguchi T, Ninomiya T, Hattori T, Kurihara S, Ozawa H, Udagawa N, Takahashi N: Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J Biol Chem 2005;280:24035-24042.
10. Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S, Okafuji N, Kurihara S, Udagawa N, Takahashi N: Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 2005;146:5204-5214.
11. 2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr Metab Immune Disord Drug Targets 2006;6:383-394.
12. Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF: Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 2000;130:2274-2284.
13. Ono K, Kaneko H, Choudhary S, Pilbeam CC, Lorenzo JA, Akatsu T, Kugai N, Raisz LG: Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 2005;20:23-29.
14. Raisz LG, Fall PM: Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 1990;126:1654-1659.
15. Shen CL, Yeh JK, Rasty J, Li Y, Watkins BA: Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 2006;95:462-468.
16. Hakeda Y, Nakatani Y, Kurihara N, Ikeda E, Maeda N, Kumegawa M: Prostaglandin E2 stimulates collagen and non-collagen protein synthesis and prolyl hydroxylase activity in osteoblastic clone MC3T3-E1 cells. Biochem Biophys Res Commun 1985;126:340-345.
17. Kajii T, Suzuki K, Yoshikawa M, Imai T, Matsumoto A, Nakamura S: Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch Oral Biol 1999;44:233-241.
18. van't Hof RJ, Ralston SH: Nitric oxide and bone. Immunology 2001;103:255-261.
19. Zheng H, Yu X, Collin-Osdoby P, Osdoby P: RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption. J Biol Chem 2006;281:15809-15820.
20. Nabhan AF: A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study. Hum Reprod 2006;21:1320-1324.
21. Hukkanen M, Hughes FJ, Buttery LD, Gross SS, Evans TJ, Seddon S, Riveros-Moreno V, Macintyre I, Polak JM: Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 1995;136:5445-5453.
22. Kanematsu M, Ikeda K, Yamada Y: Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells. J Bone Miner Res 1997;12:1789-1796.
23. Otsuka E, Yamaguchi A, Hirose S, Hagiwara H: Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol 1999;277:C132-C138.
24. Pereira RC, Delany AM, Canalis E: Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone 2002;30:685-691.
25. Priante G, Musacchio E, Pagnin E, Calo LA, Baggio B: Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells. Clin Sci (Lond) 2005;109:177-182.
26. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G: Dietary (n-3) fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003;18:1206-1216.
27. Watkins BA, Li Y, Seifert MF: Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 2006;17:282-289.
28. Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL: An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 2007;6:2.
29. Blackwell KA, Raisz LG, Pilbeam CC: Role of N-3 fatty acids in osteoclastogenesis [abstract]. J Bone Miner Res 2006;21(Suppl 1):S293.
30. Watkins BA, Li Y, Lippman HE, Feng S: Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 2003;68:387-398.
31. Shen C-L, Yeh JK, Rasty J, Chyu M-C, Dunn DM, Li Y, Watkins BA: Improvement of bone quality in gonad intact middle-aged male rats by long-chain n-3 PUFA. Calcif Tissue Int 2007;80:286-293.